|
1
|
Ambros V: The functions of animal
microRNAs. Nature. 431:350–355. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
He H, Jazdzewski K, Li W, et al: The role
of microRNA genes in papillary thyroid carcinoma. Proc Natl Acad
Sci USA. 102:19075–19080. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Voorhoeve PM, le Sage C, Schrier M, et al:
A genetic screen implicates miRNA-372 and miRNA-373 as oncogenes in
testicular germ cell tumors. Cell. 124:1169–1181. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wu L, Fan J and Belasco JG: MicroRNAs
direct rapid deadenylation of mRNA. Proc Natl Acad Sci USA.
103:4034–4039. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wei WI and Sham JS: Nasopharyngeal
carcinoma. Lancet. 365:2041–2054. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Lin J-C: Adjuvant chemotherapy in advanced
nasopharyngeal carcinoma based on plasma EBV load. J Radiat Oncol.
1:117–127. 2012. View Article : Google Scholar
|
|
8
|
Li T, Chen JX, Fu XP, et al: microRNA
expression profiling of nasopharyngeal carcinoma. Oncol Rep.
25:1353–1363. 2011.PubMed/NCBI
|
|
9
|
Jemal A, Siegel R, Ward E, et al: Cancer
statistics, 2009. CA Cancer J Clin. 59:225–249. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhang L, Deng T, Li X, et al: microRNA-141
is involved in a nasopharyngeal carcinoma-related genes network.
Carcinogenesis. 31:559–566. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Xia H, Ng SS, Jiang S, et al:
miR-200a-mediated downregulation of ZEB2 and CTNNB1 differentially
inhibits nasopharyngeal carcinoma cell growth, migration and
invasion. Biochem Biophys Res Commun. 391:535–541. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wong TS, Man OY, Tsang CM, et al: MicroRNA
let-7 suppresses nasopharyngeal carcinoma cells proliferation
through downregulating c-Myc expression. J Cancer Res Clin Oncol.
137:415–422. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Shi W, Alajez NM, Bastianutto C, et al:
Significance of Plk1 regulation by miR-100 in human nasopharyngeal
cancer. Int J Cancer. 126:2036–2048. 2010.PubMed/NCBI
|
|
14
|
Chen C, Ridzon DA, Broomer AJ, et al:
Real-time quantification of microRNAs by stem-loop RT-PCR. Nucleic
Acids Res. 33:e1792005. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Calin GA, Sevignani C, Dumitru CD, et al:
Human microRNA genes are frequently located at fragile sites and
genomic regions involved in cancers. Proc Natl Acad Sci USA.
101:2999–3004. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Sevignani C, Calin GA, Nnadi SC, et al:
MicroRNA genes are frequently located near mouse cancer
susceptibility loci. Proc Natl Acad Sci USA. 104:8017–8022. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Fåhraeus R, Fu HL, Ernberg I, et al:
Expression of Epstein-Barr virus-encoded proteins in nasopharyngeal
carcinoma. Int J Cancer. 42:329–338. 1988. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Jemal A, Siegel R, Xu J and Ward E: Cancer
statistics, 2010. CA Cancer J Clin. 60:277–300. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Sun K and Lai EC: Adult-specific functions
of animal microRNAs. Nat Rev Genet. 14:535–548. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Ameres SL and Zamore PD: Diversifying
microRNA sequence and function. Nat Rev Mol Cell Biol. 14:475–488.
2013. View
Article : Google Scholar : PubMed/NCBI
|
|
21
|
van Kouwenhove M, Kedde M and Agami R:
MicroRNA regulation by RNA-binding proteins and its implications
for cancer. Nat Rev Cancer. 11:644–656. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kasinski AL and Slack FJ: Epigenetics and
genetics. MicroRNAs en route to the clinic: Progress in validating
and targeting microRNAs for cancer therapy. Nat Rev Cancer.
11:849–864. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
23
|
Iorio MV and Croce CM: MicroRNA
dysregulation in cancer: Diagnostics, monitoring and therapeutics.
A comprehensive review. EMBO Mol Med. 4:143–159. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Valencia-Sanchez MA, Liu J, Hannon GJ and
Parker R: Control of translation and mRNA degradation by miRNAs and
siRNAs. Gene Dev. 20:515–524. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Chen HC, Chen GH, Chen YH, et al: MicroRNA
deregulation and pathway alterations in nasopharyngeal carcinoma.
Br J Cancer. 100:1002–1011. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Liu Y, Li Z, Wu L, et al: MiRNA-125a-5p: A
regulator and predictor of gefitinib's effect on nasopharyngeal
carcinoma. Cancer Cell Int. 14:242014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Li G, Liu Y, Su Z, et al: MicroRNA-324-3p
regulates nasopharyngeal carcinoma radioresistance by directly
targeting WNT2B. Eur J Cancer. 49:2596–2607. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Lu J, Getz G, Miska EA, et al: MicroRNA
expression profiles classify human cancers. Nature. 435:834–838.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Deng M, Gu Y, Zheng G, et al: Expression
and clinical significance of miR-21 in nasopharyngeal carcinoma.
Shandong Med J. 52:10–12. 2012.
|
